- Home
- CGON vs FLYW Comparison
CGON vs FLYW Comparison
Compare CGON & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- FLYW
- Stock Information
- Founded
- CGON 2010
- FLYW 2009
- Country
- CGON United States
- FLYW United States
- Employees
- CGON N/A
- FLYW N/A
- Industry
- CGON
- FLYW Computer Software: Prepackaged Software
- Sector
- CGON
- FLYW Technology
- Exchange
- CGON NYSE
- FLYW Nasdaq
- Market Cap
- CGON 1.3B
- FLYW 1.1B
- IPO Year
- CGON 2024
- FLYW 2021
- Fundamental
- Price
- CGON $20.64
- FLYW $8.88
- Analyst Decision
- CGON Strong Buy
- FLYW Buy
- Analyst Count
- CGON 10
- FLYW 15
- Target Price
- CGON $65.11
- FLYW $19.00
- AVG Volume (30 Days)
- CGON 1.3M
- FLYW 2.7M
- Earning Date
- CGON 05-08-2025
- FLYW 05-06-2025
- Dividend Yield
- CGON N/A
- FLYW N/A
- EPS Growth
- CGON N/A
- FLYW N/A
- EPS
- CGON N/A
- FLYW 0.02
- Revenue
- CGON $1,139,000.00
- FLYW $492,144,000.00
- Revenue This Year
- CGON N/A
- FLYW $13.82
- Revenue Next Year
- CGON $16,237.24
- FLYW $16.21
- P/E Ratio
- CGON N/A
- FLYW $378.45
- Revenue Growth
- CGON 461.08
- FLYW 22.09
- 52 Week Low
- CGON $14.80
- FLYW $8.20
- 52 Week High
- CGON $46.99
- FLYW $23.40
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- FLYW 34.62
- Support Level
- CGON $19.47
- FLYW $8.43
- Resistance Level
- CGON $20.63
- FLYW $9.25
- Average True Range (ATR)
- CGON 2.07
- FLYW 0.53
- MACD
- CGON 0.20
- FLYW 0.18
- Stochastic Oscillator
- CGON 48.59
- FLYW 37.26
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.